Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.22
-0.38 (-4.42%)
Sep 10, 2026, 1:15 PM CST

SHE:300016 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
583.76295.44257.46748.45766.73895.02
Trading Asset Securities
298.56379.75350.77---
Cash & Short-Term Investments
882.32675.18608.23748.45766.73895.02
Cash Growth
25.87%11.01%-18.73%-2.38%-14.33%-11.71%
Accounts Receivable
227.06265.25176.36188.55112.67142.52
Other Receivables
0.868.079.545.878.395.81
Receivables
227.92273.32185.9194.42121.06148.33
Inventory
420.17383.75362.09244.86276.22250.01
Other Current Assets
65.1744.5614.959.071412.72
Total Current Assets
1,5961,3771,1711,1971,1781,306
Property, Plant & Equipment
1,1531,125976.03876.23840.46795.3
Long-Term Investments
582.37578.74536.76556.06561.19553.2
Goodwill
46.9246.9246.92-31.8251.23
Other Intangible Assets
145.14147.22160.82128.39125.1138.99
Long-Term Accounts Receivable
-1.311.43---
Long-Term Deferred Tax Assets
38.623741.3341.3839.3218.15
Long-Term Deferred Charges
24.225.2724.9417.236.9532.4
Other Long-Term Assets
17.649.3118.113.385.838.92
Total Assets
3,6043,3482,9782,8192,8192,904

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
177.63214.38171.32115.12140.9141.13
Accrued Expenses
14.2455.0844.534.8932.0526.06
Short-Term Debt
301.48216.96140.02175.56107.6179.08
Current Portion of Long-Term Debt
27.5837.554912.410.0920.13
Current Portion of Leases
-0.923.263.042.740.27
Current Income Taxes Payable
20.987.84---0.01
Current Unearned Revenue
5.76.668.762.014.453.8
Other Current Liabilities
57.6935.0138.3816.144.8315.09
Total Current Liabilities
605.29574.39455.23359.17302.67285.56
Long-Term Debt
237.58248.79600.24592.55516.28476.1
Long-Term Leases
1.772.164.87.179.980.14
Long-Term Unearned Revenue
20.9724.5216.8411.747.8910.45
Long-Term Deferred Tax Liabilities
79.1580.570.9362.4858.5645.98
Total Liabilities
944.75930.361,1481,033895.39818.22

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
581.69562.87491.95491.93491.96492.72
Additional Paid-In Capital
834.36697.91135.34135.22135.3201.27
Retained Earnings
1,074994.58926.45912.791,0191,042
Treasury Stock
-----0.1-9.06
Comprehensive Income & Other
4.353.36113.86110.67130.27130.04
Total Common Equity
2,4952,2591,6681,6511,7761,857
Minority Interest
164.28158.45161.9135.69146.88229.03
Shareholders' Equity
2,6592,4171,8291,7861,9232,086
Total Liabilities & Equity
3,6043,3482,9782,8192,8192,904

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
568.4506.37797.32790.72646.71575.72
Net Cash (Debt)
313.92168.81-189.09-42.28120.03319.31
Net Cash Growth
-----62.41%2.79%
Net Cash Per Share
0.570.33-0.42-0.090.210.66
Filing Date Shares Outstanding
577.12562.87491.95491.93491.96492.72
Total Common Shares Outstanding
577.12562.87491.95491.93491.96492.72
Working Capital
990.28802.42715.95837.62875.341,021
Book Value Per Share
4.324.013.393.363.613.77
Tangible Book Value
2,3032,0651,4601,5221,6191,667
Tangible Book Value Per Share
3.993.672.973.093.293.38
Buildings
-699.61700.49561.7557.21532.04
Machinery
-609.14567.37503.01470.31400.02
Construction In Progress
-260.8770.26110.3944.9949